CNTO 1275

ustekinumab · Centocor, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CNTO 1275, covering 2012-11-21 to 2012-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2]